Lamivudine: An antiviral drug with high risk factor for selection of resistance in HBV patients

Hepatitis B Virus: Update in Management

Genetic Variability, Infection Kinetics, or Resistance-Associated Substitutions: Which One is Big Elephant in the Room to Eliminate Hepatitis C Virus by 2030

Prevention and Control of HCV Infection and HCV Related Chronic Disease

Evaluating the Effects of Anti-Viral Therapy on Insulin Resistance and Diabetic Status in Chronic Hepatitis C patients

Evolution of treatment of chronic hepatitis C virus infection by directly acting anti-viral therapeutics: A glimmer of hope

Antimicrobial Resistance among Sputum Pathogens in Post ‎Hepatitis C Cirrhotic Patients: a Cross-Sectional Study‎

Recent trends in chronic hepatitis C virus treatment

A Combination anti-HBV regimen using lamivudine and other agents in treatment of resistant chronic hepatitis B

Assessment of knowledge, attitudes and practice regarding hepatitis B infection among health care workers.